CAPNOSTICS

FDA cleared device for early detection of Barrett’s Esophagus and other Upper GI diseases such as cancer and H-pylori. Opportunity to launch the FDA 510k clearedNon-endoscopic swallowable screening device for esophageal bottle-brush cellular retrieval for use with new Genome Sequencing diagnostic tests (Biomarkers) that are expected to become mass "out-patient" screening tests used for the early detection of Barrett’s Esophagus and other diseases.